Literature DB >> 4435583

Radioimmunoassay of cholecystokinin-pancreozymin.

R F Harvey, L Dowsett, M Hartog, A E Read.   

Abstract

A sensitive and specific radioimmunoassay for cholecystokinin-pancreozymin (CCK-PZ) has been developed, using rabbit antisera to crude porcine hormone. Highly purified porcine CCK-PZ, labelled with (131)I, and repurified by column chromatography on Sephadex G15, was used as tracer. Separation of free from antibody-bound labelled CCK-PZ was carried out using charcoal, ion-exchange resin, or a double antibody procedure. Non-specific interference with the assay system by serum factors was abolished (as judged by in-vitro and in-vivo recovery studies) by boiling and diluting the serum samples before assay. Ninety-nine per cent pure porcine CCK-PZ (standard), commercial CCK-PZ preparations, caerulein, the C-terminal 8- and 12-amino acid fragments of the CCK-PZ molecule, and endogenous human CCK-PZ all cross reacted in the assay system and showed parallel inhibition curves. No significant cross reaction was found with gastrin, secretin, glucagon, or insulin. The sensitivity of the assay is approximately 5 pg per ml of test solution, which proved adequate for measuring physiological levels of CCK-PZ in peripheral blood in man.The mean immunoreactive CCK-PZ concentration in 50 fasting normal subjects was 60.4 pg per ml. The distribution of individual values was skewed, however, so that the median was much lower (30 pg per ml). Older subjects had higher fasting levels of CCK-PZ than were found in young adults.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4435583      PMCID: PMC1413038          DOI: 10.1136/gut.15.9.690

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  40 in total

1.  Effect of cholecystokinin on duodenal tonus and motility.

Authors:  E ADLERCREUTZ; T PETTERSSON; H ADLERCREUTZ; P GRIBBE; C WEGELIUS
Journal:  Acta Med Scand       Date:  1960-08-10

Review 2.  Radioimmunoassay in gastroenterology.

Authors:  S A Berson; R S Yalow
Journal:  Gastroenterology       Date:  1972-05       Impact factor: 22.682

3.  Effect of cholecystokinin on colonic motility and symptoms in patients with the irritable-bowel syndrome.

Authors:  R F Harvey; A E Read
Journal:  Lancet       Date:  1973-01-06       Impact factor: 79.321

Review 4.  Cholecystokinin-pancreozymin: recent developments.

Authors:  M A Ondetti; B Rubin; S L Engel; J Pluscec; J T Sheehan
Journal:  Am J Dig Dis       Date:  1970-02

5.  Three components of gastrin in human serum. Gel filtration studies on the molecular size of immunoreactive serum gastrin.

Authors:  J F Rehefeld
Journal:  Biochim Biophys Acta       Date:  1972-12-28

6.  Synthesis of cholecystokinin-pancreozymin. I. The C-terminal dodecapeptide.

Authors:  M A Ondetti; J Pluscec; E F Sabo; J T Sheehan; N Williams
Journal:  J Am Chem Soc       Date:  1970-01-14       Impact factor: 15.419

7.  Size and charge distinctions between endogenous human plasma gastrin in peripheral blood and heptadecapeptide gastrins.

Authors:  R S Yalow; S A Berson
Journal:  Gastroenterology       Date:  1970-05       Impact factor: 22.682

8.  Further studies on the nature of immunoreactive gastrin in human plasma.

Authors:  R S Yalow; S A Berson
Journal:  Gastroenterology       Date:  1971-02       Impact factor: 22.682

9.  Cholecystokinin: pharmacology and clinical use.

Authors:  S Dahlgren
Journal:  Acta Chir Scand Suppl       Date:  1966

10.  Cholecystokinin and pancreozymin, one single hormone?

Authors:  E Jorpes; V Mutt
Journal:  Acta Physiol Scand       Date:  1966 Jan-Feb
View more
  14 in total

1.  Relationship between changes of serum cholecystokinin-pancreozymin and serum insulin after different stimuli.

Authors:  J A Grayburn; R F Harvey; R D Jennings; L Dowsett; M Hartog
Journal:  Diabetologia       Date:  1975-02       Impact factor: 10.122

2.  Automated biological assay of cholecystokinin.

Authors:  C E Marshall
Journal:  Med Biol Eng       Date:  1976-05

3.  Radioimmunoassay of gastrointestinal hormones.

Authors:  P L Rayford; K Hejtmancik; J C Thompson
Journal:  World J Surg       Date:  1979-08-31       Impact factor: 3.352

4.  Immunoreactivity of the endocrine pancreas. Evidence for the presence of cholecystokinin- pancreozymin within the A-cell.

Authors:  D Grube; V Maier; S Raptis; W Schlegel
Journal:  Histochemistry       Date:  1978-06-02

5.  Serum cholecystokinin, basal acid secretion, and infantile pyloric stenosis.

Authors:  I M Rogers; I K Drainer; A J Dougal; J Black; R Logan
Journal:  Arch Dis Child       Date:  1979-10       Impact factor: 3.791

6.  Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction.

Authors:  R A Liddle; I D Goldfine; M S Rosen; R A Taplitz; J A Williams
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

7.  Effect of metiamide on basal and stimulated serum cholecystokinin levels in duodenal ulcer patients.

Authors:  R W Spence; L R Celestin; R F Harvey
Journal:  Gut       Date:  1976-11       Impact factor: 23.059

8.  Cholecystokinin metabolism in normal man and patients with duodenal ulcer.

Authors:  N I Ramus
Journal:  Ann R Coll Surg Engl       Date:  1982-11       Impact factor: 1.891

9.  The effects of glucagon, secretin, pancreozymin and pentagastrin on the hepatic arterial vascular bed of the dog.

Authors:  P D Richardson; P G Withrington
Journal:  Br J Pharmacol       Date:  1977-01       Impact factor: 8.739

10.  Pathogenesis of the impaired gall bladder contraction of coeliac disease.

Authors:  A M Brown; M J Bradshaw; R Richardson; J G Wheeler; R F Harvey
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.